ANXA6 and cancer: These studies presumably suggest that in breast and other cancer types, the proinvasive properties of AnxA6 are mediated by receptor-like properties of AnxA6, as well as by AnxA6-enriched EVs and that the mechanisms may not be limited to the activation of NF-κB and Wnt signaling as recently reported [95].